Free Trial
→ Financial legend: “This is bad, really bad...” (From Weiss Ratings) (Ad)tc pixel
OTCMKTS:AHKSY

Asahi Kasei Q4 2025 Earnings Results & Report

Asahi Kasei logo
$20.05 +0.10 (+0.50%)
As of 03:50 PM Eastern

Asahi Kasei beat analyst expectations on both earnings and revenue in its Q4 2025 results, released May 9, 2025. The company reported EPS of $0.35 versus the $0.2084 consensus estimate, while revenue of $5.36 billion topped the $5.21 billion estimate by $151.23 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Asahi Kasei EPS Results

Actual EPS
$0.35
Consensus EPS
$0.2084
Beat/Miss
Beat by +$0.1416
One Year Ago EPS
N/A

Asahi Kasei Revenue Results

Actual Revenue
$5.36 billion
Expected Revenue
$5.21 billion
Beat/Miss
Beat by +$151.23 million
YoY Revenue Growth
N/A

Upcoming Earnings

Asahi Kasei's next earnings date is estimated for Wednesday, November 4, 2026, based on past reporting schedules.

Conference Call Resources

Asahi Kasei Q4 2025 Earnings FAQ

Asahi Kasei (OTCMKTS:AHKSY) reported earnings of $0.35 per share for Q4 2025, beating the consensus estimate of $0.2084. The report was announced on Friday, May 9, 2025.

Asahi Kasei reported revenue of $5.36 billion for Q4 2025, against a consensus estimate of $5.21 billion.

Asahi Kasei's next earnings date is estimated for Wednesday, November 4, 2026. MarketBeat tracks confirmed and estimated earnings dates for Asahi Kasei on the company's earnings history page.

Asahi Kasei Earnings Headlines

Asahi Kasei Corp. (OTCMKTS:AHKSY) Stock Short Interest Report for September
October 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31105693
Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing
September 15, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260915583092/en/asahi-kasei-introduces-vantij%c2%ae-su-vfc-benchtop-to-improve-efficiency-and-consistency-in-gene-therapy-manufacturing/
Financial legend: “This is bad, really bad...”
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
October 16 at 1:00 AM  |  Weiss Ratings (Ad)
Asahi Kasei Corp ADR AHKSY
September 11, 2026  |  morningstar.comM
Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries
August 19, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260819788219/en/asahi-kasei-develops-novel-lithium-pre-doping-technology-to-raise-energy-density-and-lower-cost-of-silicon-rich-lithium-ion-batteries/
Asahi Kasei Advances Share Buyback, Plans Cancellation of Repurchased Stock
June 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/asahi-kasei-advances-share-buyback-plans-cancellation-of-repurchased-stock?utm_source=marketbeat.com&utm_medium=referral
See More Asahi Kasei Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Asahi Kasei? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Asahi Kasei and other key companies, straight to your email.

About Asahi Kasei

Asahi Kasei (OTCMKTS:AHKSY) Corporation is a diversified Japanese manufacturer serving the material, homes and health care markets. Founded in 1922 and headquartered in Tokyo, the company develops and supplies products ranging from chemicals and performance materials to medical devices and housing-related goods and services.

Its materials operations include petrochemical products, synthetic resins, elastomers, coatings and electronic materials, as well as battery separators and other components used in automobiles, electronics and industrial applications. The company also produces fibers and specialized materials for a variety of commercial and consumer uses.

Through its homes business, Asahi Kasei provides residential construction, remodeling, real estate and related services, particularly in Japan. Its health care activities include pharmaceuticals, medical devices and systems used in areas such as acute care, dialysis and therapeutic treatment. Asahi Kasei serves customers in Japan and international markets through a global network of operations and subsidiaries.

View Asahi Kasei Profile
Earnings Tools